Related Beal topped out Leiden Center II (LCII) at Innovation Square, a 345,000-square-foot life sciences development in Boston’s Raymond L. Flynn Marine Park (RLFMP). It will be fully occupied by Vertex Pharmaceuticals upon completion.
LCII, formally known as the Jeffrey Leiden Center for Biologics, Cell and Genetic Therapies II, will be the third building in the RLFMP developed by Related Beal and the second to be fully occupied by Vertex. LCII will join LCI and be known as the Leiden Campus, completing Innovation Square and delivering a new life sciences hub in Boston.
The project is led by an ownership group that includes Related Beal, Vertex, Boston Real Estate Inclusion Fund, Kavanagh Advisory Group, and Mitsui Fudosan America. The construction management team is a collaboration between Related Beal Construction, Consigli Construction and Janey Construction Management.
Construction is slated to be completed in early 2027. Related Beal said the project will be the first LEED Platinum and Zero Carbon life science building in Boston.
The post Related Beal Tops Out Second Building in Leiden Campus appeared first on Connect CRE.
​Â
